2021 Outlook: A Return to Normal? [INFOGRAPHIC]
1/20/2021
Review this visual summary of the Raymond James Investment Strategy Committee’s outlook for investors in the coming year.
Markets & Investing
Have You Hired the Right Tax Accountant?
1/20/2021
Five signs you’ve chosen the right accountant; two signs that suggest proceeding with caution.
Tax Planning
So Many Variables
1/19/2021
Doug Drabik discusses fixed income market conditions and offers insight for bond investors.
Markets & Investing
The Inflation Outlook
1/15/2021
Chief Economist Scott Brown discusses current economic conditions.
Economy & Policy
Weekly Investment Strategy
1/15/2021
Review the latest Weekly Headings by CIO Larry Adam.
Markets & Investing
Weekly Market Guide
1/15/2021
Review the latest portfolio strategy commentary from Mike Gibbs, managing director of Equity Portfolio & Technical Strategy.
Markets & Investing
Weekly Market Snapshot
1/15/2021
Chief Economist Scott Brown discusses the latest market data.
Economy & Policy
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
This Should Be a Bright – If Bumpy – Year for Stocks
1/11/2021
While 2021 will likely be a positive year for equities, the longer-term outlook is clouded by the potential for higher taxes, higher interest rates and lower valuations.
Markets & Investing
Expect Policy Change for Taxes, Climate, Consumer Protection
1/11/2021
Washington Policy Analyst Ed Mills discusses the policy and market implications of the U.S. election results.
Economy & Policy
